Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images.
Wei MuLei JiangYu ShiIlke TunaliJhanelle E GrayEvangelia KatsoulakisJie TianRobert J GilliesMatthew B SchabathPublished in: Journal for immunotherapy of cancer (2022)
Hence, we propose DLS as a surrogate or substitute for IHC-determined PD-L1 measurement to guide individual pretherapy decisions pending in larger prospective trials.